The good, the bad, and the ugly: sodium-glucose cotransporter-2 inhibitors (gliflozins) and perioperative diabetes

R Kerridge¹, I Whyte, F Prior², J Luu³, D A Story⁴

Affiliations

¹ Director, Perioperative Service, John Hunter Hospital, Newcastle, New South Wales.
² Director, Hunter Drug Information Service, Conjoint Senior Lecturer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales.
³ Clinical Lead Diabetes Stream, Hunter New England Local Health District, Conjoint Lecturer, School of Medicine & Public Health, Faculty of Health & Medicine, University of Newcastle, Newcastle, New South Wales.
⁴ Professor and Chair of Anaesthesia Head of Anaesthesia, Perioperative and Pain Medicine Unit (APPMU), The University of Melbourne, Melbourne, Victoria.

PMID: 29519216
DOI: 10.1177/0310057X1804600202

Editorial

The good, the bad, and the ugly: sodium-glucose cotransporter-2 inhibitors (gliflozins) and perioperative diabetes

R Kerridge et al. Anaesth Intensive Care. 2018 Mar.

. 2018 Mar;46(2):155-158.

doi: 10.1177/0310057X1804600202.

Authors

R Kerridge¹, I Whyte, F Prior², J Luu³, D A Story⁴

Affiliations

¹ Director, Perioperative Service, John Hunter Hospital, Newcastle, New South Wales.
² Director, Hunter Drug Information Service, Conjoint Senior Lecturer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales.
³ Clinical Lead Diabetes Stream, Hunter New England Local Health District, Conjoint Lecturer, School of Medicine & Public Health, Faculty of Health & Medicine, University of Newcastle, Newcastle, New South Wales.
⁴ Professor and Chair of Anaesthesia Head of Anaesthesia, Perioperative and Pain Medicine Unit (APPMU), The University of Melbourne, Melbourne, Victoria.

PMID: 29519216
DOI: 10.1177/0310057X1804600202

No abstract available

PubMed Disclaimer

Comment in

Perioperative cessation of sodium-glucose cotransporter-2 inhibitors: 72 hours or seven days?
Tan H, Acharya S. Tan H, et al. Anaesth Intensive Care. 2018 Jul;46(4):425. Anaesth Intensive Care. 2018. PMID: 29966119 No abstract available.
Functional assessment tools in the intensive care unit: are we comparing apples and oranges?
Taylor A, Sarode V, Brewster DJ. Taylor A, et al. Anaesth Intensive Care. 2018 Nov;46(6):627-628. Anaesth Intensive Care. 2018. PMID: 30447674 No abstract available.
It's hard to kill off an old paradigm-starvation in the midst of plenty.
McLoughlin PD. McLoughlin PD. Anaesth Intensive Care. 2018 Nov;46(6):628. Anaesth Intensive Care. 2018. PMID: 30447675 No abstract available.

Comment on

Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature.
Chacko B, Whitley M, Beckmann U, Murray K, Rowley M. Chacko B, et al. Anaesth Intensive Care. 2018 Mar;46(2):215-219. doi: 10.1177/0310057X1804600212. Anaesth Intensive Care. 2018. PMID: 29519226

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The good, the bad, and the ugly: sodium-glucose cotransporter-2 inhibitors (gliflozins) and perioperative diabetes

Affiliations

The good, the bad, and the ugly: sodium-glucose cotransporter-2 inhibitors (gliflozins) and perioperative diabetes

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Research Materials